SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-006569
Filing Date
2021-05-10
Accepted
2021-05-10 06:36:04
Documents
14
Period of Report
2021-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20210510x8k.htm   iXBRL 8-K 36349
2 EX-99.1 imgn-20210510xex99d1.htm EX-99.1 138636
3 GRAPHIC imgn-20210510xex99d1001.jpg GRAPHIC 5023
  Complete submission text file 0001558370-21-006569.txt   312375

Data Files

Seq Description Document Type Size
4 EX-101.SCH imgn-20210510.xsd EX-101.SCH 2986
5 EX-101.LAB imgn-20210510_lab.xml EX-101.LAB 16755
6 EX-101.PRE imgn-20210510_pre.xml EX-101.PRE 9902
7 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20210510x8k_htm.xml XML 4642
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 21905154
SIC: 2834 Pharmaceutical Preparations